136 related articles for article (PubMed ID: 3081065)
1. Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.
Taylor J; Afrasiabi R; Fahey JL; Korns E; Weaver M; Mitsuysau R
Blood; 1986 Mar; 67(3):666-71. PubMed ID: 3081065
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results.
Afrasiabi R; Mitsuyasu RT; Nishanian P; Schwartz K; Fahey JL
Am J Med; 1986 Dec; 81(6):969-73. PubMed ID: 2948385
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy.
Mitsuyasu RT; Taylor JM; Glaspy J; Fahey JL
Cancer; 1986 Apr; 57(8 Suppl):1657-61. PubMed ID: 3081246
[TBL] [Abstract][Full Text] [Related]
4. T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS.
Spornraft P; Fröschl M; Ring J; Meurer M; Goebel FD; Ziegler-Heitbrock HW; Riethmüller G; Braun-Falco O
Br J Dermatol; 1988 Jul; 119(1):1-9. PubMed ID: 3261596
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.
Chachoua A; Krigel R; Lafleur F; Ostreicher R; Speer M; Laubenstein L; Wernz J; Rubenstein P; Zang E; Friedman-Kien A
J Clin Oncol; 1989 Jun; 7(6):774-80. PubMed ID: 2565954
[TBL] [Abstract][Full Text] [Related]
6. Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style.
Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR
Cancer Res; 1984 Dec; 44(12 Pt 1):5894-901. PubMed ID: 6209006
[TBL] [Abstract][Full Text] [Related]
7. Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
Vadhan-Raj S; Wong G; Gnecco C; Cunningham-Rundles S; Krim M; Real FX; Oettgen HF; Krown SE
Cancer Res; 1986 Jan; 46(1):417-25. PubMed ID: 2415251
[TBL] [Abstract][Full Text] [Related]
8. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
Safai B; Sarngadharan MG; Koziner B; Godbold J; Myskowski PL; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
Cancer Res; 1985 Sep; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700
[TBL] [Abstract][Full Text] [Related]
10. Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma.
Schroff RW; Gottlieb MS; Prince HE; Chai LL; Fahey JL
Clin Immunol Immunopathol; 1983 Jun; 27(3):300-14. PubMed ID: 6603314
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma and AIDS: a variable spectrum.
Shepherd FA; Hogg-Johnson S; Fleshner N; Read SE; Fanning MM; Johnson K; Goss P; Coates RA
Clin Invest Med; 1989 Dec; 12(6):367-73. PubMed ID: 2612089
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
Otu AA
J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
[TBL] [Abstract][Full Text] [Related]
13. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.
Euler HH; Kern P; Löffler H; Dietrich M
Clin Exp Immunol; 1985 Feb; 59(2):267-75. PubMed ID: 3156700
[TBL] [Abstract][Full Text] [Related]
14. AIDS-associated Kaposi's sarcoma: variables associated with survival.
Myskowski PL; Niedzwiecki D; Shurgot BA; Kaufman D; Krown SE; Nisce L; Safai B
J Am Acad Dermatol; 1988 Jun; 18(6):1299-306. PubMed ID: 2968378
[TBL] [Abstract][Full Text] [Related]
15. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.
Fahey JL; Prince H; Weaver M; Groopman J; Visscher B; Schwartz K; Detels R
Am J Med; 1984 Jan; 76(1):95-100. PubMed ID: 6229182
[TBL] [Abstract][Full Text] [Related]
16. [Immune activation in AIDS related Kaposi's sarcoma].
Zhu B; Wu NP; Hoxtermann S; Bader A; Brockmeyer N
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 32(2):101-3. PubMed ID: 12734931
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
Albrecht H; Helm EB; Plettenberg A; Emminger C; Heise W; Schwartländer B; Stellbrink HJ
Genitourin Med; 1994 Dec; 70(6):394-8. PubMed ID: 7705856
[TBL] [Abstract][Full Text] [Related]
18. Clinical variants and staging of Kaposi's sarcoma.
Mitsuyasu RT
Semin Oncol; 1987 Jun; 14(2 Suppl 3):13-8. PubMed ID: 3603056
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
[TBL] [Abstract][Full Text] [Related]
20. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
